Episode Overview

Podcast: Endocrine News Podcast
Episode: ENP89: Brown Fat and Metabolic Function
Host: Aaron Lohr
Guest: Dr. Marcel Lino, Research Fellow at Joslin Diabetes Center
Date: August 21, 2024

In this episode, host Aaron Lohr interviews Dr. Marcel Lino about the latest findings on brown fat and its surprising roles in human metabolic function. Dr. Lino discusses new insights from his recent research on how brown fat communicates with other organs through exosomal microRNAs, potentially offering new avenues for metabolic disease therapies.

Key Discussion Points and Insights

1. What is Brown Fat? (01:01)

• Brown fat is a specialized fat type found mainly in the back and subclavicular regions.
• Unlike white fat, which stores energy and is associated with obesity, brown fat burns energy—a process linked to better metabolic and cardiovascular health.
  • Dr. Lino: “Brown fat, once active, can actually expend vast amounts of energy and secrete a lot of factors that will improve your overall metabolic health...” (01:08)

2. Origin and Distribution of Brown Fat (01:29)

• Brown fat arises from a unique precursor, likely related to smooth muscle cells (Myf5 positive lineage).
• Humans have significantly less brown fat than rodents:
  • Infants have abundant brown fat; its quantity declines with age.
  • The physiological significance and health benefits persist even with less mass in adults.
• Studies link brown fat activity (not just quantity) to improved cardiometabolic outcomes in humans.
  • Dr. Lino: “Despite there being potentially less brown fat mass in humans than rodents, there was an association between brown fat activity and improved cardiometabolic outcomes.” (02:51)

3. Exosomes and Brown Fat Communication (04:01)

• Exosomes are small vesicles secreted by nearly all cells, but adipose tissue—especially brown fat—can increase exosome secretion when stimulated (by cold, drugs, possibly exercise).
• Exosomes can carry regulatory factors, notably microRNAs (miRNAs), which can influence distant organs’ metabolic functions.

4. Dr. Lino’s Study on Brown Fat and Exosomal microRNAs (05:10)

• Aim: Understand how brown fat regulates body-wide metabolism through mobile microRNAs, which act as endocrine signals.
• Key Method: Developed a method to label microRNAs derived specifically from brown fat, then trace their journey into other organs.
• Discovery: Brown fat–derived microRNAs are highly mobile, often enriching in specific organs.
  • Example: 31 unique microRNAs from brown fat preferentially accumulated in the hypothalamus (brain), largely bypassing the liver and muscle.
  • Dr. Lino: “We saw very robust labeling... micrornas were very good at transferring from brown fat to the liver, to the muscle, into the hypothalamus. ...31 micrornas...became specifically targeted to the hypothalamus.” (06:23)
• This suggests a targeting mechanism for microRNAs that’s not fully understood.

5. Innovative RNA Labeling Techniques (07:32)

• Technique: Genetically engineered mice express a bacterial enzyme only in brown fat. When fed a modified uracil, it incorporates into brown fat RNAs, uniquely marking them.
• This allows researchers to identify RNA molecules originating in brown fat in distant tissues.
  • “If it ends up into the rna, we can purify that rna. ...when we're detecting...in the brain and the liver, there was quite a lot of RNA that was labeled, even though the enzyme was not in those tissues, which told us that the RNA had to be coming from brown fat and ending up in those tissues.” (07:40)

6. Why Understanding microRNA Transport Matters (09:09)

• Knowing how and where microRNAs are produced and transported is vital for:
  • Moving beyond simple association studies or biomarkers.
  • Developing targeted RNA-based therapies for metabolic diseases.
• Without knowing the source and target, it's hard to translate findings into therapeutics.
  • Dr. Lino: “If you don't know where it is originating from and where it is acting on, it makes it difficult to extend it beyond the biomarker stage into something that's more therapeutic.” (09:53)
• The “holy grail” is figuring out how to deliver microRNAs specifically to tissues that need them.

7. Clinical Implications and Future Directions (11:07)

• RNA-based therapies could revolutionize endocrine and metabolic disease management due to high specificity and tunability.
• Learning how microRNAs target organs may drastically improve drug design and delivery systems.
  • “If we can figure some of this information out, it can give us a lot of new tools that we can use in the drug design pipeline...” (12:13)

8. Dr. Lino’s Personal and Research Future (12:45)

• Dr. Lino is focused on concluding and publishing current research.
• Long-term aspirations include running his own lab to continue this line of investigation, though he's open to evolutionary shifts in his career path.
  • “I think there are sometimes when you’re doing something that’s so exciting for you...you tend to forget [plans].” (12:54)

Notable Quotes & Memorable Moments

• Dr. Lino, on new findings:
  “Some of these micrornas…actually tended to become enriched in specific organs—for example, the hypothalamus…despite the fact that they all originated from brown fat…So it seems like there is a targeting mechanism here that we don’t understand.” (06:40)

• On the importance of source-target identification:
  “If you wanted to, for say, say, okay, let. Seven is an important. Micro RNA has been implicated in obesity. Is it beneficial in some organs and detrimental to some others, and which organ is making it? …The biggest challenge, of course, sort of holy grail…being, can I get it there and deliver it there specifically?” (10:42)

• On RNA-based therapies:
  “They present a unique and very powerful opportunity to make specialized medicines, not only because they're very tunable from individual to individual, but ...the actual nucleotide sequence itself is very specific and encodes a lot of information in a very small space.” (11:14)

• Career reflections:
  “If I were to say right now I’d like to have my own lab in the future...but if I go back 10 years, I don’t think I would have envisioned being where I am now. So why limit myself to saying this is what I'm going to do. And who knows?” (13:29)

Episode Timeline

| Timestamp | Segment | |-----------|-----------------------------------------------------------------| | 00:00 | Intro: Brown fat and metabolic function | | 01:01 | What is brown fat? | | 01:29 | Origins and comparative biology (humans vs. mice) | | 03:52 | Exosomes and their connections to brown fat | | 05:10 | Dr. Lino’s recent study: Methods and discoveries | | 07:32 | Innovative RNA labeling tool | | 09:09 | Why tissue-to-tissue microRNA transport matters | | 10:52 | Potential for clinical impact, RNA therapies | | 12:45 | Dr. Lino’s personal future and research ambitions |

Conclusion

This episode offers a deep dive into the cutting edge of brown fat research, particularly focusing on how brown fat may be communicating across organs through exosomal microRNAs. Dr. Lino’s discoveries open important new questions about tissue signaling and the future of RNA-based therapies—a field poised for major advances in personalized metabolic medicine.